Literature DB >> 9041088

Secondary implantation of open-loop, flexible, anterior chamber intraocular lenses.

C R Ellerton1, S M Rattigan, F M Chapman, D K Chitkara, D L Smerdon.   

Abstract

PURPOSE: To assess the results of implantation of secondary, open-loop, flexible, anterior chamber intraocular lenses (IOLs) and compare the findings with those of other published studies.
SETTING: A combined ophthalmology and ear, nose, and throat hospital in Middlesbrough, Cleveland, England.
METHODS: This retrospective study comprised 81 patients who had secondary implantation of a flexible, open-loop, anterior chamber IOL by the one surgeon. The incidence of postoperative complications was ascertained, and best corrected preoperative and postoperative visual acuities were compared.
RESULTS: Two serious complications occurred: one severe loss of vision that is still under investigation and one retinal detachment that was repaired with good residual visual function. Of all 81 patients, 92.5% were within one Snellen line of their preoperative best corrected visual acuity. These results compare favorably with those of other published studies.
CONCLUSION: Using an open-loop, flexible, anterior chamber lens for secondary implantation is still an acceptable way to treat aphakia. The poor reputation of these lenses is undeserved.

Entities:  

Mesh:

Year:  1996        PMID: 9041088     DOI: 10.1016/s0886-3350(96)80197-0

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  10 in total

1.  Combined pars plana lensectomy-vitrectomy with open-loop flexible anterior chamber intraocular lens (AC IOL) implantation for subluxated lenses.

Authors:  S Kazemi; W J Wirostko; S Sinha; W F Mieler; S B Koenig; B P Sheth
Journal:  Trans Am Ophthalmol Soc       Date:  2000

2.  Upside-down lens syndrome: ocular complications secondary to inverted implantation of the Kelman Multiflex anterior chamber intraocular lens.

Authors:  Robert E Fintelmann; Shane K Kim; David G Hwang
Journal:  Am J Ophthalmol       Date:  2011-05-12       Impact factor: 5.258

3.  Visual outcomes after lensectomy and iris claw artisan intraocular lens implantation in patients with Marfan syndrome.

Authors:  Hossein Mohammad Rabie; Parviz Malekifar; Mohammad Ali Javadi; Danial Roshandel; Hamed Esfandiari
Journal:  Int Ophthalmol       Date:  2016-10-05       Impact factor: 2.031

4.  Secondary intraocular lens interventions: predisposing factors, indications and coincident procedures.

Authors:  Alejandro Lichtinger; Peter Kim; Sonia N Yeung; Maoz D Amiran; Manreet Alangh; David S Rootman
Journal:  Int Ophthalmol       Date:  2012-09-25       Impact factor: 2.031

5.  Iris-claw, retropupillary-fixated, aphakic intraocular lens implantation for traumatic aphakia following penetrating keratoplasty.

Authors:  Anas A Anbari
Journal:  Digit J Ophthalmol       Date:  2015-05-07

6.  Iris Claw versus Scleral Fixation Intraocular Lens Implantation during Pars Plana Vitrectomy.

Authors:  Fereydoun Farrahi; Mostafa Feghhi; Foad Haghi; Ali Kasiri; Abbas Afkari; Mahmood Latifi
Journal:  J Ophthalmic Vis Res       Date:  2012-04

7.  Flanged intraocular lens (IOL) implantation with scleral pockets - A modification of flanged IOL technique (E-Flanged IOL) for secondary lens implantation.

Authors:  Hitesh K Agrawal; Mudit Tyagi; Komal Agarwal; Padmaja K Rani
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 1.848

8.  Secondary IOL Implantation without Capsular Support: A Laser Flare Cell Meter Study.

Authors:  Mauro Cellini; Ernesto Strobbe; Pier Giorgio Toschi; Emilio C Campos
Journal:  ISRN Ophthalmol       Date:  2012-01-02

9.  Surgical refixation of posteriorly dislocated intraocular lens with scleral-tuck technique.

Authors:  Pukhraj Rishi; Ekta Rishi; Aditya Maitray
Journal:  Indian J Ophthalmol       Date:  2017-05       Impact factor: 1.848

10.  Retropupillary iris-claw intraocular lens implantation in aphakic patients.

Authors:  C V Sumitha; Vijay Pai; Mithun Thulasidas
Journal:  Indian J Ophthalmol       Date:  2020-04       Impact factor: 1.848

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.